Nexilina (Lacosamide)

Lacosamide is an antiepileptic drug that works on neuronal sodium channels to control seizure activity.

• Partial‑onset seizures: reduces the frequency of focal seizures.
• Epilepsy (adjunctive therapy): improves overall seizure control when added to existing regimens.
• Refractory focal epilepsy: provides an additional option for patients not responding to other antiepileptic drugs.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing hyperexcitability. It also binds to the collapsin response mediator protein‑2 (CRMP‑2), further modulating neuronal signaling and contributing to its antiepileptic effect.

Lacosamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness or imbalance.
• Headache: mild to moderate pain in the head region.
• Nausea: feeling of stomach upset or urge to vomit.
• Fatigue: unusual tiredness or lack of energy.
• Blurred vision: temporary visual disturbances.
• Diplopia: double vision in some patients.

Serious or Rare Side Effects

• Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Cardiac arrhythmia: irregular heart rhythm, including atrial fibrillation.
• Severe allergic reactions: anaphylaxis or angioedema.
• Liver injury: signs of hepatic dysfunction.
• Respiratory depression: marked reduction in breathing effort.

Before initiating therapy with Lacosamide, clinicians should consider several safety measures.

• Cardiac assessment: evaluate ECG in patients with known heart disease.
• Renal function: monitor kidney function, especially in severe impairment.
• Concomitant CNS depressants: assess risk of enhanced sedation when combined with other depressants.
• Dizziness counseling: advise patients to avoid driving or operating machinery until they know how the drug affects them.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Lacosamide can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma levels.
• Strong CYP3A4 inducers (e.g., carbamazepine): may reduce therapeutic effectiveness.
• Other sodium‑channel blockers (e.g., phenytoin): risk of additive toxicity.
• QT‑prolonging agents (e.g., sotalol): heightened risk of cardiac arrhythmias.
• Alcohol: can potentiate central nervous system depression.

Moderate Interactions (Monitor Closely)

• Moderate CYP3A4 inhibitors (e.g., erythromycin): may modestly raise drug concentrations.
• Moderate CYP3A4 inducers (e.g., rifampin): may modestly lower efficacy.
• Oral contraceptives: possible reduction in hormonal effectiveness.
• Antacids: may affect absorption if taken simultaneously.
• NSAIDs: increased risk of gastrointestinal irritation.